Michael F. Mahoney - 08 Aug 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: Chairman, President & CEO, Director
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 08 Aug 2022
Net transactions value: -$3,978,658
Form type: 4
Filing time: 09 Aug 2022, 16:31:36 UTC
Previous filing: 05 May 2022
Next filing: 07 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$610,170	+82,567	+3.9%	$7.39^*	2,215,689	08 Aug 2022	Direct	F1
transaction	BSX	Common Stock	Options Exercise	$565,854	+43,261	+2%	$13.08	2,258,950	08 Aug 2022	Direct	F1
transaction	BSX	Common Stock	Sale	$5,154,682	-125,828	-5.6%	$40.97	2,133,122	08 Aug 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Stock Option (Right to Buy)	Options Exercise	$0	-43,261	-13%	$0.000000	302,822	08 Aug 2022	Common Stock	43,261	$13.08	Direct	F1, F3
transaction	BSX	Stock Option (Right to Buy)	Options Exercise	$0	-82,567	-25%	$0.000000	247,701	08 Aug 2022	Common Stock	82,567	$7.39	Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2	Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $40.72 to $41.23, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3	Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
F4	Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.